Product Information
MUCUS RLF DM MAX ER 1200-60 MG is a generic product labeled by Rugby Laboratories, priced at $0.5446 per EA under NDC 00536121388. Its NADAC has been published 402 times since Jan 23, 2019.
FDA first approved this application on Nov 1, 2018.
Strength
60; 1200 mg/1; mg/1
Manufacturer
Rugby LaboratoriesNDC
00536121388
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA209692FDA Approved
11/1/2018
On Market Since
11/5/2018
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RLF DM MAX ER 1200-60 MG has been published 402 times since Jan 23, 2019, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5446 per EA |
|---|---|
| All-time high | $0.6365 (May 13, 2020) |
| All-time low | $0.4830 (Aug 18, 2021) |
| 52-week high | $0.5493 |
| 52-week low | $0.5233 |
| Median price | $0.5459 |
| Average price | $0.5465 |
| Largest weekly change | +12.2% (Sep 23, 2020) |
| Weeks tracked | 402 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin, Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RLF DM MAX ER 1200-60 MG?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RLF DM MAX ER 1200-60 MG, manufactured by Rugby Laboratories, is $0.5446 per EA (NDC 00536121388), effective Sep 30, 2026.
How has the price of MUCUS RLF DM MAX ER 1200-60 MG changed over time?
Over the history we have for it, the NADAC for MUCUS RLF DM MAX ER 1200-60 MG has declined 12.2%. It has been tracked across 402 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for MUCUS RLF DM MAX ER 1200-60 MG?
Since Jan 23, 2019, the NADAC for MUCUS RLF DM MAX ER 1200-60 MG has ranged from a low of $0.4830 (Aug 18, 2021) to a high of $0.6365 (May 13, 2020), with a median of $0.5459 per EA.
Are there cheaper alternatives to MUCUS RLF DM MAX ER 1200-60 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MUCUS RLF DM MAX ER 1200-60 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures MUCUS RLF DM MAX ER 1200-60 MG?
MUCUS RLF DM MAX ER 1200-60 MG (NDC 00536121388) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.